Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 206

Results For "company"

4867 News Found

Eiko LifeSciences inks business agreement with Vivacious Pharmatex
News | January 28, 2024

Eiko LifeSciences inks business agreement with Vivacious Pharmatex

The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials


Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
Drug Approval | January 28, 2024

Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana

The company intends to respond to the two minor observations within the stipulated time


Novartis India posts Q3 FY24 PAT at Rs. 26.57 Cr
News | January 28, 2024

Novartis India posts Q3 FY24 PAT at Rs. 26.57 Cr

Novartis India has reported total income of Rs. 106.50 crores during the period ended December 31, 2023


Laurus Labs inks JV agreement with KRKA, Slovenia
News | January 26, 2024

Laurus Labs inks JV agreement with KRKA, Slovenia

The registered capital of the newly founded company is € 50 million


Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr
News | January 26, 2024

Syngene Q3 FY 24 PAT up 4% to Rs 115 Cr

For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)


Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr
News | January 26, 2024

Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr

Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023


Zydus receives USFDA’s final approval for Gabapentin Tablets, 300 mg and 600 mg
Drug Approval | January 26, 2024

Zydus receives USFDA’s final approval for Gabapentin Tablets, 300 mg and 600 mg

Gabapentin is indicated for the management of Postherpetic Neuraligia


Strides receives USFDA approval for Pregabalin Capsules
Drug Approval | January 26, 2024

Strides receives USFDA approval for Pregabalin Capsules

The Pregabalin capsules has a market size of ~US$248 mn per IQVIA


Shilpa Medicare directed to to pay damage to Celltrion
News | January 25, 2024

Shilpa Medicare directed to to pay damage to Celltrion

The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement


Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr
News | January 25, 2024

Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr

Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023